Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in China
20 of 44 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Where
- Fuzhou, Jinan, Nanjing, Xiamen
- Age
- 18 years to 85 years
- People
- 750 worldwide
- Run by
- Pulnovo Medical, Inc.
See details and how to joinNCT07214376 - Phase 3Taking peopleA Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
- Where
- Beijing, Changsha, Nanjing, Qingdao, Shanghai, Xi'an
- Age
- 2 years and over
- People
- 280 worldwide
- Run by
- Actelion
See details and how to joinNCT05179876 · EU 2023-506791-27-00 - No phaseTaking peopleVasopressor Agents in Pulmonary Hypertension Crisis
- Where
- Beijing, Guangzhou, Wuhan
- Age
- 18 years and over
- People
- 75
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07667829 - No phaseNot yet taking people in ChinaCTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support
- Where
- Beijing
- Age
- 18 years and over
- People
- 60
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT07902011 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Beijing, Changsha, Guangzhou, Shanghai
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - Phase 1/2Taking peopleCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
- Where
- Beijing
- Age
- 10 years to 65 years
- People
- 45
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06947460 - Phase 1/2Taking peopleA Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guiyang, Hangzhou, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Shanghai, Shenyang, Tianjin, Wuhan, Xiamen, Xuzhou, Zhengzhou
- Age
- 18 years to 75 years
- People
- 120
- Run by
- ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
See details and how to joinNCT07593027 - Early phase 1Taking peoplePercutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study
- Where
- Xiamen
- Age
- 18 years to 80 years
- People
- 60
- Run by
- Xiamen Cardiovascular Hospital, Xiamen University
See details and how to joinNCT07662655 - No phaseTaking peopleEfficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 120
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07604805 - No phaseTaking peopleClose Loop Smart Weaning for INO With PPHN
- Where
- Shanghai
- People
- 30
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT06832163 - Phase 1Taking peopleA Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
- Where
- Beijing
- Age
- 18 years and over
- People
- 72
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06554301 - Phase 1/2Taking peopleUmbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
- Where
- Beijing
- Age
- 6 years to 65 years
- People
- 45
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06947473 - No phaseTaking peopleContinuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 104
- Run by
- RenJi Hospital
See details and how to joinNCT07149935 - No phaseTaking peopleComparison of Sequential to Initial Combination Therapy in PAH
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 376
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06968962 - No phaseTaking peopleStudy on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 48
- Run by
- Beijing Chao Yang Hospital
See details and how to joinNCT06980584 - Phase 3Taking peopleRiociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)
- Where
- Beijing
- Age
- 18 years and over
- People
- 68
- Run by
- Suqiao Yang
See details and how to joinNCT06922240 - No phaseTaking peopleInhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)
- Where
- Lhasa
- Age
- 18 years to 65 years
- People
- 100
- Run by
- Novlead Inc.
See details and how to joinNCT06852924 - No phaseTaking peopleMobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
- Where
- Beijing
- Age
- 18 years to 60 years
- People
- 80
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06362382 - No phaseTaking peopleFreeFlow Percutaneous Atrial Septal Shunt for IPAH
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06605794 - No phaseTaking peoplePotts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension
- Where
- Beijing
- Age
- 6 months to 18 years
- People
- 120
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT06429579